Releases

Media coverage

Newsletter

Subscribe to our newsletter

Archive


Sep 20, 2014
September 19.th Øystein Rekdal was invited as guest speaker at Karolinska Institutet (KI) in Stockholm, Sweden. The title on his lecture was "The oncolytic peptide LTX-315 represents a novel immunotherapeutic strategy".

Rekdal received good response from the immunoncology research mileu at KI.